scispace - formally typeset
B

Blaise Genton

Researcher at University of Lausanne

Publications -  241
Citations -  10715

Blaise Genton is an academic researcher from University of Lausanne. The author has contributed to research in topics: Malaria & Population. The author has an hindex of 49, co-authored 226 publications receiving 9683 citations. Previous affiliations of Blaise Genton include West Health & University Hospital of Lausanne.

Papers
More filters
Journal ArticleDOI

Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine.

TL;DR: This trial tests the ability of a third-generation vaccine, containing PreS1 and PreS2 antigens in addition to the S antigen, to elicit seroprotective titres in documented non- and low-responders, compared with those to a conventional vaccine.
Journal ArticleDOI

Prospective Study of a Serogroup X Neisseria meningitidis Outbreak in Northern Ghana

TL;DR: The occurrence of serogroup X outbreaks argues for the inclusion of this serogroups into a multivalent conjugate vaccine against N. meningitidis, and three closely related clusters with distinct patterns of spread were identified among the Ghanian isolates.
Journal ArticleDOI

Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity.

TL;DR: A reduction in the incidence rate of clinical malaria observed in individuals with high antibody concentration to MSP-1 may be due to antibodies directed against epitopes within the C-terminal region of M SP-1.
Journal ArticleDOI

Low quality of routine microscopy for malaria at different levels of the health system in Dar es Salaam

TL;DR: The quality of routine microscopy was poor in all health facilities, regardless of their level, and over-diagnosis was massive, with many false positive results reported as very low parasitaemia.
Journal ArticleDOI

A single LC-tandem mass spectrometry method for the simultaneous determination of 14 antimalarial drugs and their metabolites in human plasma.

TL;DR: A liquid chromatography-tandem mass spectrometry method requiring 200mul of plasma for the simultaneous determination of 14 antimalarial drugs and their metabolites which are the components of the current first-line combination treatments for malaria is developed.